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Human renal epithelial cells produce the long pentraxin PTX3.
Background. Pentraxin 3 (PTX3) is a prototypic long pen-
traxin with structural similarities in the C-terminal domain to
the classical short pentraxins C-reactive protein (CRP) and
serum amyloid P component. PTX3 is suggested to play an im-
portant role in the innate resistance against pathogens, regula-
tion of inflammatory reactions, and clearance of apoptotic cells.
Unlike the classic pentraxins, PTX3 is mainly expressed extra-
hepatically. The present study was designed to investigate the
expression of PTX3 by human proximal renal tubular epithelial
cells (PTECs).
Methods. PTECs were cultured in the presence or absence
of inflammatory cytokines. PTX3 mRNA expression was mea-
sured by reverse transcription-polymerase chain reaction (RT-
PCR) in human kidney and PTECs. PTX3 protein levels in
PTEC cultures were quantified by enzyme-linked immunosor-
bent assay (ELISA).
Results. PTX3 mRNA was shown to be constitutively ex-
pressed in human kidney. Constitutive expression and produc-
tion of PTX3 was shown in primary mesangial cells, in primary
PTECs, and in renal fibroblasts. Further analysis showed that
interleukin (IL)-1 and tumor necrosis factor-a (TNF-a) stimula-
tion strongly enhanced the expression and production of PTX3
in PTECs in a dose- and time-dependent manner. In addition,
activation of PTECs with IL-17 and CD40L, respectively, but
not with IL-6 or IL-4, resulted in strongly increased production
of PTX3, whereas granulocyte macrophage-colony-stimulating
factor (GM-CSF) inhibited IL-1–induced PTX3 production.
PTX3 produced by PTEC is functionally active in binding C1q.
Conclusion. These results indicate that PTX3 is expressed
and released by PTECs and that in proinflammatory conditions
PTX3 production is up-regulated. Local expression of PTX3
may play a role in the innate immune response and inflamma-
tory reactions in the kidney.
Pentraxins are acute-phase proteins, characterized by
a cyclic pentameric structure, that show a strong inter-
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species homology [1]. The classical short pentraxins, C-
reactive protein (CRP), and serum amyloid P component
(SAP) are produced in the liver in response to inflam-
matory mediators, most prominently interleukin (IL)-6
[2, 3]. Short pentraxins contribute to innate immune re-
sponses to microbes and are involved in the scavenging
of cellular debris [4, 5].
PTX3, also called tumor necrosis factor (TNF)-
stimulated gene 14, is the first cloned long pentraxin,
structurally related to, yet distinct from, classic short pen-
traxins. The C-terminal half of the protein aligns with the
full-length sequence of CRP and SAP, whereas the N-
terminal region of the protein does not show any signifi-
cant homology with other proteins. PTX3 was originally
cloned as a gene highly induced by IL-1 in endothelial
cells [6] and by TNF-a in fibroblasts [7]. PTX3 is produced
by a variety of cell types, mainly endothelial cells and cells
of the monocyte/macrophage lineage, upon stimulation
with inflammatory mediators [8].
We have previously demonstrated that PTX3 binds
C1q and activates the classical complement pathway [9,
10]. Furthermore, PTX3 participates in the clearance
of apoptotic cells and several micro-organisms [11, 12].
Transgenic mice overexpressing the PTX3 gene showed
an excessive inflammatory response to endotoxic shock
and sepsis, resulting in a more effective control of infec-
tion and longer survival [13]. However, during ischemia/
reperfusion (I/R) injury the increased inflammatory re-
sponse in PTX3 transgenic mice resulted in a higher de-
gree of tissue damage and enhanced lethality [14]. Serum
levels of PTX3 are elevated in a number of human dis-
orders, such as myocardial infarction [15], rheumatoid
arthritis [16], and sepsis [17]. Taken together, these find-
ings suggest an important role for PTX3 in the regulation
of inflammatory reactions and innate immunity.
Many renal diseases are characterized by an influx of
monocytes and T lymphocytes in the tubulointerstitium.
These infiltrating cells contribute to the inflammatory
response in the kidney by the release of inflammatory
mediators, such as IL-1 and TNF-a, thereby activating
543
544 Nauta et al: PTX3 production by renal tubular epithelial cells
resident renal tubular epithelial cells. Several studies have
shown that activated tubular epithelial cells produce large
amounts of chemokines, cytokines, and complement com-
ponents [18–23]. Therefore, tubular epithelial cells are
considered to play an important role in inflammatory pro-
cesses within the kidney.
In the present study we examined whether PTX3 is ex-
pressed in the kidney. We observed that PTX3 mRNA
is constitutively expressed in normal human kidney. We
also investigated the constitutive and inducible expres-
sion and production of PTX3 in different renal cells,
including tubular epithelial cells. Stimulation with IL-1,
TNF-a, IL-17, and CD40L increases the expression and
production of PTX3 by renal epithelial cells. The produc-
tion of PTX3 in the kidney may contribute to local innate
resistance and inflammation.
METHODS
Immunohistochemistry
Immunostaining was performed on rejected kidneys
from patients with acute allograft rejection. Renal tissue
was fixed in formalin and embedded in paraffin. Tissue
sections (4 lm thick) were dewaxed and rehydrated. En-
dogenous peroxidase activity was blocked by incubation
in methanol and 0.3% hydrogen peroxide. Sections were
microwave-heated at 100◦C for 10 minutes in 0.1 mol/L
sodium citrate (pH 6), and subsequently rinsed with
water and phosphate-buffered saline (PBS). The sec-
tions were incubated with 10% normal goat serum, fol-
lowed by affinity-purified rabbit anti-PTX3 polyclonal
antibody (1lg/mL) at a dilution of 1/1000, washed in PBS,
incubated with goat antirabbit IgG-poly-horseradish
peroxidase antiserum (Immunologic, Duiven, The
Netherlands), and peroxidase activity was visualized us-
ing diaminobenzidine and hydrogen peroxide.
Cell culture
Proximal tubular epithelial cells (PTECs). Primary
human PTECs were isolated from kidneys not suitable
for transplantation and from pretransplantation biop-
sies [24]. Cell monolayers were cultured on a matrix of
heat-inactivated fetal calf serum (FCS) (Gibco BRL/Life
Technologies, Inc., Paisley, UK) in Dulbecco’s modified
Eagle’s medium (DMEM)/Ham-F12 (Bio-Whittaker,
Walkersville, MD, USA), supplemented with insulin
(5 lg/mL), transferrin (5 lg/mL), selenium (5 ng/mL), hy-
drocortisone (36 ng/mL), trio-iodothyronine (40 pg/mL),
epidermal growth factor (EGF) (10 ng/mL) (all from
Sigma Chemical Co., St. Louis, MO, USA), and 100 U/mL
penicillin/100 lg/mL streptomycin (P/S) (Gibco/Life
Technologies, Inc.) [25]. Specific outgrowth of PTECs
was confirmed by morphologic appearance and im-
munofluorescent staining as described [26]. For passage
of the culture, cells were harvested by trypsinization
with 0.05% (wt/vol) trypsin/0.02% (wt/vol) ethylenedi-
aminetetraacetic acid (EDTA) (Sigma Chemical Co.).
PTECs obtained between passage 2 and 6 of culture were
used for experiments.
Human kidney 2 (HK-2). The immortalized PTEC-
derived cell line HK-2 was kindly provided by M.J. Ryan,
University College Dublin, Ireland [27]. HK-2 cells are
being widely used for in vitro studies of human PTECs
displaying most characteristics of primary cells. Cells
were cultured in DMEM/Ham-F12 supplemented as de-
scribed above.
L cells. Mouse fibroblast L cells, stably transfected
with human CD40L (L-CD40L), have been described
previously [28]. Nontransfected L cells (L orient) were
used as a negative control. Cells were cultured in RPMI
1640 supplemented with 10% inactivated FCS and P/S.
L cells were irradiated (80 Gy) before coculture experi-
ments to prevent overgrowth of the cultures.
TK173. The human fibroblast cell line TK173 was
kindly provided by F. Strutz, Department of Nephrol-
ogy and Rheumatology, Georg-August University,
Germany. Cells were cultured in Iscove’s modified Dul-
becco’s medium (IMDM) supplemented with 10% inac-
tivated FCS and P/S [29].
Adult mesangial cells (AMC). Primary AMCs were
isolated from human kidneys not suitable for transplanta-
tion. AMCs were cultured and characterized as described
previously [30].
Cell stimulation
PTEC or HK-2 were trypsinized and transferred to
48-well plates (Costar, Corning, NY, USA) at a cell
concentration of 0.5 × 105 cells per well. After 24 hours,
stimulation experiments were performed using the
following cytokines: IL-1a, IL-1b (1 ng/mL) (both from
Preprotech, Rocky Hill, NJ, USA), TNF-a (40 ng/mL)
(R&D Systems, Minneapolis, MN, USA), IL-17 (50
ng/mL) (R&D Systems), IL-4 (10 ng/mL) (Peprotech),
IL-6 (80 ng/mL) (Sanbio, Uden, The Netherlands),
granulocyte macrophage-coloncy stimulating fac-
tor (GM-CSF) (80 ng/mL) (Leucomax) (Novartis
Pharma BV, Arnhem, The Netherlands), macrophage
colony stimulating factor (M-CSF) (80 ng/mL),
interferon-c (IFN-c) (80 ng/mL) (Boehringer Ingel-
heim, Alkmaar, The Netherlands) for 48 hours unless
indicated otherwise. Irradiated L cells were added in a
1:1 ratio.
RNA isolation and reverse transcription-polymerase
chain reaction (RT-PCR)
Total RNA from cells and from tissue was isolated us-
ing RNAzol (Campro, Veenendaal, The Netherlands),
according to the description of the manufacturer. Tis-
sue samples were first homogenized using an ultraturrax
(IKA Labortechnik, Staufen, Germany). Alternatively,
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Table 1. Primer sequences
Human gene Primer sequence Corresponding base Product size Accession number
PTX3 X63613
Forward ‘5-CAT CCA GTG AGA CCA ATG AG-3’ 656–675 287 bp
Reverse ‘5-GTA GCC GCC AGT TCA CCA TT-3’ 923–942
GAPDH M33197
Forward ‘5-ACC ACA GTC CAT GCC ATC AC-3’ 585–604 452 bp
Reverse ‘5-TCC ACC ACC CTG TTG CTG TA-3’ 1017–1036
Abbreviations are: PTX3, pentraxin 3; GAPDH, glyceraldehyde-3-phosphate dehydrogenase
total RNA was isolated by means of RNeasy Mini Kit
(Qiagen, Venlo, The Netherlands). The quantity and pu-
rity of the isolated RNA was determined by measuring
the ratio of optical densities at 260 and at 280 nm.
Fixed amounts of total RNA (1 lg) were reverse tran-
scribed into cDNA by oligo-dT priming using Moloney
murine leukemia virus (M-MLV) reverse transcriptase
(Gibco/Life Technologies). The amplification of cDNA
by PCR was performed using the primers as described
in Table 1. Expression of glyceraldehyde-3-phosphatate
dehydrogenase (GAPDH) mRNA was used as a control.
PCR was performed under standard conditions in a final
volume of 40 lL [50 mmol/L KCl, 10 mmol/L Tris-HCl,
pH 8.4, 2 mmol/L MgCl2, 0.06 mg/mL bovine serum albu-
min (BSA), 0.25 mmol/L deoxynucleoside triphosphate
(dNTP), 25 pmol of each primer, and 1 U of Taq poly-
merase] (Perkin Elmer, Norwalk, CT, USA). Amplifica-
tion of cDNA started with 5 minutes at 95◦C, followed by
35 cycles of 1 minute at 95◦C, 1 minute at 55◦C, 1 minute
at 72◦C, and the final primer extension for 7 minutes at
72◦C. PCR products were analyzed on a 1% agarose gel
containing ethidium bromide. The intensity of the bands
was determined by densitometry, using EaglySight soft-
ware (Stratagene, La Jolla, CA, USA).
Enzyme-linked immunosorbent assay (ELISA)
The concentration of PTX3 secreted in culture super-
natants was measured using a sandwich ELISA [17]. For
the detection of PTX3, 96-well Nunc Maxisorb microtiter
plates (Nunc, Roskilde, Denmark) were coated overnight
at 4◦C with 1 lg/mL of the rat monoclonal antibody
MNB4 antihuman PTX3 in coating buffer (0.1 mol/L
sodium carbonate, pH 9.6). All reaction volumes were
100 lL and plates were washed after each step in PBS
containing 0.05% vol/vol Tween. Plates were incubated
for 1 hour at 37◦C with PBS containing 1% wt/vol BSA
to block uncoated sites. Cell supernatants or recombi-
nant human PTX3 standards (purified from supernatant
of Chinese hamster ovary cells stably and constitutively
expressing the protein [9]), for quantification, were added
to the wells, diluted in PBS containing 0.05% Tween and
1% BSA. Following 1 hour of incubation at 37◦C, bound
PTX3 was detected using biotin-conjugated polyclonal
rabbit anti-PTX3 antibody, followed by incubation with
streptavidin conjugated to poly horseradish peroxidase
(CLB, Amsterdam, The Netherlands). Finally, 2,2′-azino-
bis 3-ethylbenzthiazoline-6-sulfonic acid (Sigma Chemi-
cal Co.) was added for color development and optical
density at 415 nm was assessed. Alternatively, wells were
coated with 5 lg/mL serum-purified C1q, prepared as de-
scribed previously [31]. PTX3 binding was detected as
indicated above. Production of IL-6 was measured in the
supernatant by specific ELISA as described previously
[24].
Western blotting
For Western blot analysis, supernatants of stimulated
cells (concentrated 40-fold by Speedvac) were boiled for
5 minutes in 3 × sodium dodecyl sulfate (SDS) sam-
ple buffer (New England Biolabs, Beverly, MA, USA),
separated by SDS-polyacrylamide gel electrophoresis
(PAGE), and blotted on polyvinyldene fluoride (PVDF)
membranes (Immobilon-p) (Millipore, Bedford, MA,
USA). Membranes were incubated with 2% casein in
PBS containing 0.05% Tween for blocking and then
the primary antibody biotin-conjugated monoclonal rat
anti-PTX3 antibody MNB4 was added. After incuba-
tion with horseradish peroxidase-conjugated streptavidin
(Bio-Rad, Hercules, CA, USA) as a secondary reagent,
detection was performed with Supersignal (Pierce, Rock-
ford, IL, USA) and the blots were exposed to Hyper-
filmTM films (Amersham Pharmacia Biotech, UK).
Statistical analysis
Protein production data are presented as mean ± SD of
absolute values of representative experiments performed
in triplicate. Alternatively, data are presented as rela-
tive increases as compared to control cultures, using the
mean ± standard error of the mean (SEM) of multiple ex-
periments performed in triplicate. Statistical analysis of
relative increases of protein production upon cell stimu-
lation was performed using two-way analysis of variance
(ANOVA). P values were considered statistically signifi-
cant when P was below 0.05.
RESULTS
Expression of PTX3 in renal biopsies
Renal tissue from patients with acute allograft rejec-
tion was analyzed for expression of PTX3 by immuno-
histochemistry. Intense staining for PTX3 was mainly
observed in tubulointerstitial areas of leukocytic infiltra-
tion (Fig. 1A). In detail, staining was especially present at
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Fig. 1. Expression of pentraxin 3 (PTX3) in
renal allografts with acute rejection. Renal
tissue sections were stained for PTX3 as de-
scribed in the Methods section. PTX3 staining
is detectable in the inflamed interstitium (A),
often at sites of cell-cell and cell-matrix inter-
action (B and C). Tubular epithelial cells show
a faint staining for PTX3 (C). Control stain-
ing, in the absence of the primary antibody, is
negative (D) [original magnification (A) ×40;
(B and D) ×200; (C) ×800].
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Fig. 2. Pentraxin 3 (PTX3) is expressed in
the kidney. (A) Total RNA was isolated from
adult human kidney, from the cortex, from
the medulla and from isolated glomeruli,
and reverse transcription-polymerase chain
reaction (RT-PCR) was performed for PTX3
and glyceraldehyde-3-phosphate dehydroge-
nase (GAPDH). (B) Expression of PTX3
by primary mesangial cells, renal fibroblasts,
epithelial-derived cell line human kidney 2
(HK-2), and primary renal tubular epithelial
cells was analyzed by RT-PCR. For PTX3 and
GAPDH, cDNA was diluted up to 1000 times,
as indicated.
cell-cell and cell-matrix interaction sites (Fig. 1B and C).
Focal weak staining was observed on tubular epithelial
cells (Fig. 1C). Control staining was negative (Fig. 1D).
In contrast to this positive staining in renal tissue showing
acute rejection, normal renal tissue stained negative for
PTX3 (results not shown).
Expression of the PTX3 gene in kidney
Adult human kidney was tested for the mRNA ex-
pression of the PTX3 gene. Total mRNA was isolated
from total kidney as well as from renal cortex, medulla
and glomeruli. By RT-PCR analysis we observed PTX3
mRNA to be present in all the different compartments
of the kidney (Fig. 2A). We next examined the ability
of different renal cells to express the PTX3 transcript
by RT-PCR. PTX3 gene expression was detected in pri-
mary mesangial cells and in renal fibroblasts, in accor-
dance with previous publications [7, 32]. In addition, we
observed expression of PTX3 mRNA by renal proximal
tubular epithelial cells (Fig. 2B).
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Fig. 3. Pentraxin 3 (PTX3) mRNA expres-
sion by interleukin (IL)-1b- and tumor necro-
sis factor-a (TNF-a)-stimulated renal epithe-
lial cells. Human kidney 2 (HK-2) (A and
C) or primary human proximal tubular ep-
ithelial cells (PTECs) (B and D) were stim-
ulated with medium, IL-b (1 ng/mL) or
TNF-a (40 ng/mL). (A and B) After 6 hours,
RNA was isolated and a semiquantitative
reverse transcription-polymerase chain reac-
tion (RT-PCR) was performed for PTX3 and
glyceraldehydes-3-phosphate dehydrogenase
(GAPDH). (C and D) Quantification of the
mRNA expression of PTX3 by calculating
mRNA levels of PTX3 relative to those of
GAPDH using densitometry analysis. Mea-
surements of ratios in control cultures were
assigned a relative value of 1, representing
control values. Results are expressed as mean
± SD of two independent experiments.
Cytokine modulation of PTX3 gene expression in renal
epithelial cells
The observed expression of PTX3 mRNA by renal
tubular epithelial cells, as well as the proposed role of
tubular epithelial cells in inflammatory processes in the
kidney [33], prompted us to further investigate the ex-
pression of PTX3 by human PTECs and to define its
modulation by cytokines in vitro. Primary PTECs or
the PTEC-derived cell line HK-2 were stimulated with
human recombinant IL-1b or TNF-a. These proinflam-
matory cytokines have been described to induce PTX3
expression in monocytes and endothelial cells [8]. As
shown in Figure 3, both IL-1b and TNF-a strongly in-
creased PTX3 mRNA expression in HKs2 cells (Fig. 3A)
and in primary PTECs (Fig. 3B). Compared to basal
PTX3 expression, PTX3 mRNA expression was about
eightfold increased by IL-1b and threefold increased by
TNF-a, both in HK-2 cells and in primary PTECs (Fig. 3C
and D). Affymetrix gene chip analysis confirmed our find-
ings, demonstrating that PTX3 is constitutively expressed
by primary PTECs. Stimulation with IL-1a for 20 hours
resulted in a 2.4-fold increase in PTX3 expression level
(Simone de Haij, unpublished observations).
PTX3 protein production
Having established that PTX3 mRNA is expressed
in PTECs, we examined whether PTX3 protein was in-
deed released. Western blot experiments were performed
under reducing conditions with supernatant from non-
stimulated and IL-1b–stimulated HK-2 cells. The results
presented in Figure 4 show that under basal conditions a
specific signal for PTX3 protein is detectable at the cor-
rect molecular weight (45 kD) [9], indicating that PTX3
kD
51
34
Rec PTX3 Medium IL-1β
HK2
Fig. 4. Detection of pentraxin 3 (PTX3) secreted by renal epithelial
cells. Human kidney 2 (HK-2) cells were stimulated with medium or
interleukin (IL)-1b (1 ng/mL) for 48 hours. Supernatant was harvested,
concentrated 40-fold, and analyzed by Western blotting with a biotiny-
lated mouse anti-PTX3 monoclonal antibody. Recombinant PTX3 pu-
rified from Chinese hamster ovary cells was used as a positive control,
as indicated. Molecular weight markers (ovalbumin, 52 kD, and car-
bonic anhydrase, 34 kD) are indicated. PTX3 production measured by
enzyme-linked immunosorbent assay (ELISA): HK-2 medium, 35 ± 15
ng/mL; HK-2 IL-1b , 3622 ± 364 ng/mL.
is secreted. Stimulation with IL-1b strongly increased the
production of PTX3.
PTX3 production by renal epithelial cells after activation
by cytokines
The production of PTX3 by renal cells was more specif-
ically quantified by ELISA. The production of PTX3 by
primary PTECs under basal conditions showed a high
variability within the different cell lines, ranging from
21 pg/mL to 321 pg/mL PTX3 per 48 hours (N = 6). As
previously reported, both IL-1b and TNF-a can stimu-
late PTECs to produce a large variety of inflammatory
mediators, including IL-6 [34]. The production of PTX3
by primary PTECs (Fig. 5A) and HK-2 cells (Fig. 5B)
was clearly up-regulated in the presence of IL-1b and
TNF-a. Exposure to IL-1b and TNF-a also increased the
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Fig. 5. Pentraxin 3 (PTX3) production by re-
nal epithelial cells stimulated with interleukin
(IL)-1b or tumor necrosis factor-a (TNF-a).
Human kidney 2 (HK-2) cells (A), pri-
mary human proximal tubular epithelial cells
(PTECs) (B), TK173 cells (C), and adult
mesangial cells (AMC) (D) were stimu-
lated with IL-1b (1 ng/mL) or TNF-a (80
ng/mL). Supernatants were harvested and
were tested for PTX3 and IL-6 production.
Primary PTECs were incubated for various
time-periods in the absence or presence of
IL-1b or TNF-a. Supernatants were harvested
and assessed for PTX3 (E) and IL-6 (F) pro-
duction. PTECs were activated with increas-
ing concentrations of IL-1b (G) or TNF-a
(H). After 48 hours, supernatants were har-
vested and tested for PTX3 and IL-6 produc-
tion. Results are expressed as mean of tripli-
cate cultures and are representative for three
independent experiments.
production of PTX3 by renal fibroblast cell line TK173
(Fig. 5C) and primary AMCs (Fig. 5D).
The production of PTX3 by primary PTECs was time-
dependent and already after 16 hours of culture, the stim-
ulatory effect of IL-1b and TNF-a on PTX3 production
could be observed (Fig. 5E). Comparable with the reg-
ulation and kinetics of PTX3 production, both IL-1b
and TNF-a showed a time-dependent increase in IL-6
production, as assessed in parallel in the same super-
natants (Fig. 5F). A significant increase, compared with
background productions, was found with 20 pg/mL of
IL-1b , and increasing amounts of IL-1b showed a dose-
dependent increase in PTX3 production (Fig. 5G). Simi-
lar results were obtained with IL-1a, another molecular
form of IL-1, binding to the same set of specific IL-1 re-
ceptors [34] (data not shown). Furthermore, also TNF-a
enhanced the production of PTX3 in a dose-dependent
fashion, showing a significant increase at 2.5 ng/mL
(Fig. 5H). Similar dose-response curves were found for
IL-6 and with HK-2 cells (data not shown).
Since previous studies have demonstrated that next to
IL-1b and TNF-a, also IL-17 can stimulate PTECs to
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Fig. 6. Pentraxin 3 (PTX3) production in re-
sponse to different cytokines. Human kidney
2 (HK-2) cells (A and B) or primary human
proximal tubular epithelial cells (PTECs) (C
and D) were stimulated for 48 hours with
interleukin (IL)-1b (1 ng/mL), tumor necro-
sis factor-a (TNF-a) (40 ng/mL), IL-17 (50
ng/mL), IL-4 (40 ng/mL), or IL-6 (80 ng/mL).
After 48 hours, supernatants were harvested
and tested for PTX3 (A and C) and IL-6 (B
and D) production. The stimulation index was
calculated using ratio of production by stim-
ulated cells and production by nonstimulated
cells. Data represent the mean stimulation in-
dex ± SEM of four independent experiments
performed in triplicate. ∗P < 0.01; ∗∗P < 0.001
compared with medium. ND = not done.
produce various inflammatory mediators [35], we exam-
ined the effect of this stimulus on the production of PTX3.
A significant increase of PTX3 production by PTECs
upon stimulation with IL-1b , TNF-a, and IL-17 (Fig. 6A
and C) was observed, comparable with the regulation of
IL-6 production (Fig. 6B and D). No effects were found
with IL-4 on PTX3 production, whereas a stimulatory
effect was observed on IL-6 production.
IL-1 and CD40L synergistically enhance
PTX3 production
Our group previously demonstrated that combined ac-
tivation of PTECs with IL-1 and CD40L resulted in syner-
gistic effects on IL-6, IL-8, and regulated upon activation,
normal T cell expressed and secreted (RANTES) (CCL5)
production [34]. Therefore, we examined whether PTX3
production was modified after stimulation with CD40L-
transfected L cells (L-CD40L). Production of PTX3 was
strongly increased after stimulation with CD40L, both
in HK-2 cells (Fig. 7A) and primary PTECs (Fig. 7B).
Next, we investigated the effect of combined stimulation
of PTECs on the production of PTX3. Stimulation of pri-
mary PTECs with a combination of IL-1b and CD40L re-
sulted in synergistic effects on PTX3 production (Fig. 7C).
A 89% ± 35% increase was found for the combination,
as compared to the sum of the stimuli alone, in three out
of four primary PTEC lines.
Negative regulation of PTX3 production
IL-6 is an important mediator of the acute phase re-
sponse and induces the expression of SAP and CRP. In
contrast, the expression of PTX3 was not up-regulated by
addition of exogenous IL-6 (Fig. 6A). Furthermore, IL-4,
IFN-c, GM-CSF, and M-CSF were unable to induce the
expression of PTX3 in primary PTECs (data not shown),
which is in line with the previously described effect of
these mediators on the expression of PTX3 by human
monocytes [8]. It was of interest to investigate whether
cytokines or growth factors could down-regulate the pro-
duction of PTX3. A modest downregulation of the IL-1–
stimulated production of PTX3 was observed by IFN-c
(23.8% ± 3.7%). Interestingly, GM-CSF strongly in-
hibited the IL-1b–induced PTX3 protein production by
HK-2 cells (Fig. 8A), whereas it had no effect on the
production of IL-6 (Fig. 8B). The inhibitory effect of
GM-CSF was dose-dependent and complete inhibition
was reached with 80 ng/mL GM-CSF.
PTX3 produced by renal epithelial cells can bind C1q
To demonstrate the functional activity of PTX3 pro-
duced by PTECs its capacity to bind C1q was exam-
ined. Therefore, wells coated with C1q were incubated
with culture supernatant from nonstimulated and IL-
1b–stimulated HK-2 cells, and PTX3 binding was an-
alyzed. Both PTX3 in HK-2 supernatant and purified
PTX3 showed strong binding to C1q (Fig. 9).
DISCUSSION
PTX3 is suggested to be important in the regulation of
inflammatory reactions and innate immunity and, in view
of this role, we have examined the expression of PTX3
in the kidney. Immunohistochemistry on renal tissue of
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patients with acute allograft rejection showed that PTX3
was predominantly present in the inflamed tubulointer-
stitium in close proximity of tubular epithelial cells. Fur-
thermore, focal weak staining for PTX3 was observed on
tubular epithelial cells. Moreover, constitutive expression
of PTX3 mRNA was shown in primary mesangial cells, in
renal fibroblasts and in primary PTECs using RT-PCR.
Activation of PTECs with the proinflammatory cytokines
IL-1b , TNF-a, and IL-17, and stimulation with CD40L,
resulted in strongly increased expression and production
of PTX3 that is able to interact with C1q.
PTX3, a prototypic long pentraxin, has been shown
to be expressed by several cell types, most promi-
nently by endothelial cells and monocytes [6, 8], in re-
sponse to inflammatory stimuli including IL-1, TNF-a,
and lipopolysaccharide (LPS). In the present study we
demonstrate that PTX3 mRNA is expressed in human re-
nal cortex, medulla, and in the glomeruli. Previous studies
demonstrated that PTX3 is expressed and produced by
mesangial cells [32] and that the expression of PTX3 can
be induced in fibroblasts upon stimulation with TNF-a
[6]. Next to glomerular mesangial cells and renal fibrob-
lasts, we now demonstrate that also renal PTECs may
contribute to the local production of PTX3 in the kidney.
PTECs have been described to be an important source
of inflammatory mediators and are therefore considered
as a central cell type in the renal inflammatory response
[33]. The expression and production of PTX3 by PTECs
is increased by proinflammatory signals provided by IL-
1, TNF-a, IL-17, and CD40L. Furthermore, combined
activation of PTECs with IL-1 and CD40L resulted in
synergistic effects on the production of PTX3, in agree-
ment with previous studies on the production of IL-6, IL-
8, and RANTES (CCL5) [34]. Inflammatory mediators
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such as IL-1 and TNF-a, derived from both infiltrat-
ing cells and activated resident renal cells, and CD40L-
expressing cells have been demonstrated to be present
in the kidney during renal inflammation [34, 35]. There-
fore, we hypothesize that the local production of these
inflammatory mediators and the presence of CD40L sub-
sequently increases PTX3 production by PTECs.
We found that other cytokines, including IL-6, IL-4,
IFN-c, M-CSF, and GM-CSF were ineffective in increas-
ing the expression and production of PTX3 by PTECs, as
previously reported for monocytes [8]. In sharp contrast,
stimulation of PTECs with IL-6 was reported to induce
the expression and production of CRP, whereas incuba-
tion with IL-1 and TNF-a had no stimulatory effect [36].
Moreover, GM-CSF specifically inhibits the secretion of
PTX3, but not IL-6, by PTECs stimulated with IL-1. Re-
cent studies have reported that certain cytokines can in-
hibit PTX3 expression by monocytes (IL-4 and IFN-c),
or synoviocytes [transforming growth factor-b (TGF-b)]
[8, 16, 37]. We observed that IFN-c was partially able to
inhibit PTX3 production by IL-1–stimulated PTECs. So
far no inhibitory effect of GM-CSF on PTX3 expression
has been described. Since GM-CSF can be produced by
PTECs after stimulation with inflammatory mediators,
including IL-1 and TNF-a [38], it is tempting to speculate
that the production of PTX3 can be down-regulated by
endogenously produced GM-CSF as a feedback mech-
anism. Such mechanisms may also influence PTX3 pro-
duction in inflamed renal tissue in vivo.
PTX3 is the first identified member of the long pen-
traxins that are structurally related to the classic short
pentraxins, such as SAP and CRP. However, the long
pentraxins differ from short pentraxins for the presence
of an unrelated long N-terminal domain, gene organiza-
tion, chromosomal localization, cellular source, and in-
ducing stimuli. SAP and CRP have been described to be
mainly produced in the liver in response to IL-6 [2, 3],
whereas the major site of synthesis of PTX3 is extrahep-
atic. However, in a recent study, CRP was described to
be also produced locally in the kidney by renal epithe-
lial cells, and was suggested to play a role in the local
inflammatory response [36].
The function of PTX3 has not been completely defined.
The regulated expression of PTX3 by cells present in pe-
ripheral tissue [15–17], as well as its capacity to bind C1q
and activate complement [10], suggest that PTX3 plays
a role in the regulation of inflammatory reactions and
innate resistance. This hypothesis is supported by stud-
ies in transgenic mice overexpressing PTX3 and stud-
ies with PTX3-deficient mice [11, 13]. PTX3 transgenic
mice were more protected against endotoxic shock and
sepsis, whereas PTX3-deficient mice were more suscepti-
ble to microbial pathogens. The increased expression of
PTX3 under inflammatory conditions may support the
clearance of damaged self-material, based on the capac-
ity of PTX3 to bind apoptotic cells [12]. Several studies
reported the presence of apoptotic cells in the kidney
in renal disease [39]. Cell death by apoptosis is thought
to play an important role in the recovery after renal in-
jury by the clearance of excess numbers of resident renal
cells and potentially injurious infiltrated leukocytes [40].
PTX3 could be involved in mediating the clearance of
apoptotic cells, thereby contributing to the resolution of
inflammation.
Alternatively, increased expression of PTX3 during in-
flammation may be pathogenic. The localization of PTX3
at cell-cell and cell-matrix sites in renal tissue of patients
with acute allograft rejection suggests that PTX3 may
play a role in adhesion. Recently, PTX3 was shown to
play an important role in the organization of extracel-
lular matrix by cross-linking of hyaluronan via interac-
tion with TNF-a–stimulated gene 6 (TSG6) [41]. TSG6
has been reported to enhance interaction between CD44
and hyaluronan, implicated in the primary adhesion of
leukocytes to endothelium at sites of inflammation [42].
Therefore, PTX3 could facilitate the CD44-mediated re-
cruitment of inflammatory cells, and contribute to inflam-
mation.
PTX3 may also amplify complement-mediated tissue
damage in pathologic situations such as I/R injury [14].
CRP has previously been reported to be an important me-
diator of tissue damage in myocardial infarction, via ac-
tivation of complement [43]. Recently, PTX3 was shown
to enhance tissue factor expression by endothelial cells,
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which is involved in the occurrence of thrombogenesis
and vascular ischemia [44]. In addition, PTX3 can activate
mesangial cells leading to cell contraction and synthesis
of the proinflammatory lipid mediator platelet-activating
factor [32]. PTX3 might contribute to the local inflamma-
tory process by activating resident renal cells. So far, no
specific membrane receptor for PTX3 has been described.
CONCLUSION
We have demonstrated that renal tubular epithelial
cells are able to produce PTX3 that is up-regulated under
inflammatory conditions. Future studies are required to
define the exact role and significance of the local expres-
sion and production of PTX3 in the kidney.
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